# So-Young International Inc.

> Clarifo company profile — qualitative business description generated from
> the company's filings. Financial statements, charts and ratios are
> available on Clarifo (https://www.clarifo.com/fi/companies/So-Young International Inc.).

## Overview

So-Young International Inc. operates an online-and-offline medical aesthetics platform in China that connects consumers with aesthetic treatment information, appointment booking, and treatment services. The company also runs branded aesthetic centers and develops, produces, and distributes optoelectronic medical equipment and injectable products for the beauty and medical aesthetics market.

## Products & services

• Online aesthetic treatment platform and reservation services
• Branded aesthetic centers / self-operated clinics
• Curated treatment information and consumer discovery tools
• Optoelectronic medical equipment
• Injectable medical aesthetics products

- **Aesthetic treatment platform services** (35%) — Consumer-facing online services that provide treatment information and reservations.
- **Aesthetic center services** (45%) — Offline medical aesthetics treatments delivered through branded centers.
- **Medical aesthetics equipment** (10%) — Optoelectronic devices used in aesthetic treatment settings.
- **Injectable products** (10%) — Injectable medical aesthetics products developed and distributed by the company.

- Online aesthetic treatment platform and reservation services
- Branded aesthetic centers / self-operated clinics
- Curated treatment information and consumer discovery tools
- Optoelectronic medical equipment
- Injectable medical aesthetics products

## Customers

So-Young serves consumers seeking medical aesthetic services, including patients looking for treatments, clinic bookings, and product-based procedures. It also sells to or through its own treatment centers and channel partners in the medical aesthetics ecosystem, where product quality, affordability, and service consistency are important buying criteria.

- **Consumer treatment users** (primary) — Individuals searching for aesthetic procedures, pricing, and appointments on the platform.
- **Aesthetic center patients** (primary) — Consumers receiving treatments at company-operated branded centers.
- **Medical aesthetics product buyers** (secondary) — Clinics and ecosystem participants purchasing equipment and injectable products.

- Consumers seeking aesthetic treatment information and bookings
- Patients using branded aesthetic centers for in-person treatments
- Buyers of optoelectronic equipment for aesthetic procedures
- Customers for injectable medical aesthetics products
- Users seeking affordable, curated treatment options

## Geography

So-Young is centered in China, where its platform, aesthetic centers, and product distribution are focused. The company also maintains investor-relations and market access links in the United States and Hong Kong through its Nasdaq listing, but its operating footprint and revenue exposure are primarily China-based.

- Primary operating market is China
- Platform and aesthetic centers serve Chinese consumers
- Products are developed, produced, and distributed in China
- US and Hong Kong links reflect listing and communications
- China concentration drives regulatory and demand exposure

## Strategy

So-Young’s strategy is to combine online consumer traffic with offline aesthetic centers, creating a full-service medical aesthetics ecosystem. It is also extending along the value chain into equipment and injectable products, which can support service differentiation, supply-chain control, and cross-selling across the platform and center network.

- **Store network expansion** (medium-term) — More centers increase geographic reach and provide a direct offline revenue base.
- **Traffic-to-treatment conversion** (short-term) — Online discovery and booking improve conversion into higher-value offline treatments.
- **Value-chain extension** (medium-term) — Equipment and injectable products deepen control over supply and support monetization.

- Expand the aesthetic center network and increase center productivity
- Use the online platform to generate traffic and bookings
- Grow along the medical aesthetics value chain
- Develop and distribute proprietary equipment and injectables
- Strengthen brand recognition and consumer trust

## Risks

So-Young depends on consumer demand for aesthetic treatments, which can be sensitive to discretionary spending, competition, and changes in public preferences. The business is also exposed to China-specific regulatory oversight of medical aesthetics, while its product and center operations create execution risk around quality, safety, and growth of newly opened locations.

- **China consumer demand sensitivity** [high] — Aesthetic treatments are discretionary, so traffic and bookings depend on consumer confidence and spending power.
- **Regulatory and compliance risk in medical aesthetics** [high] — Treatment delivery, devices, and injectables are subject to healthcare and product regulation in China.
- **Center ramp-up and execution risk** [medium] — New centers require time to reach maturity and can absorb fixed operating costs before scaling.
- **Reputation and quality control risk** [high] — Consumer trust is essential in aesthetics, and adverse treatment or product issues can hurt demand.

- China demand is discretionary and can weaken in slower consumer periods
- Medical aesthetics is regulated and subject to licensing and compliance risk
- New centers can take time to ramp and may underperform expectations
- Product quality and treatment safety are critical to brand reputation
- Goodwill and long-lived assets can require impairment charges

## Accounting

The company uses several non-GAAP adjustments that mainly affect comparability, including share-based compensation and impairment-related items. Reported results can also be shaped by goodwill, long-lived asset, and investment fair-value assessments, while center expansion and product mix can create meaningful quarter-to-quarter operating variation.

- **Share-based compensation** — Affects operating profit and net income presentation
- **Impairment of goodwill and long-lived assets** — Can create large non-cash charges in reported results
- **Fair value changes in long-term investments** — Can move earnings even when core operations are stable
- **Center ramp-up accounting** — Creates seasonality and comparability issues across quarters

- Non-GAAP excludes share-based compensation from operating profit
- Goodwill and long-lived asset impairment can affect reported earnings
- Investment fair value changes and disposal gains/losses matter
- Center ramp-up creates period-to-period revenue and cost volatility
- Cash and short-term investments are relevant for liquidity assessment

---

*Last updated: 2026-09-28T12:14:05.752298+00:00*